NPIL SET TO BUY PATHOLOGICAL LABS FOR RS 60 CRORE

Article Abstract:

Nicholas Piramal India Limited (NPIL) has drawn up plans to acquire a chain of pathological labs in the next three months. It will enter into equity understandings, valued at Rs60 crore, with large pathological labs in Delhi, Calcutta, Mumbai, Bangalore and Hyderabad. NPIL will hold 80 per cent of the equity though not go in for an outright purchase. It has already entered into such a deal with Tribeni and Roy of Calcutta. Besides this, Nicholas proposes to form a joint venture with three foreign partners to carry out phase-III clinical trials for new drugs, provide ambulatory care and offer insurance and healthcare products to corporates and individuals.(uh)

Acquisitions & mergers, Scientific Research and Development Services, R&D Facilities, Laboratories

---

NPIL IN 3-WAY JV FOR FOOD ADDITIVES

Article Abstract:

Nicholas Piramal India Limited (NPIL), a drug formulations and food additives producer, has signed a 3-way tie-up with a British and a US company. The tie-up is for making food additives. This is part of NPIL's plan to focus on exports. NPIL proposes to earn Rs150 crore through exports in 1999-2000 (Rs30 crore projected for 1998-99). It proposes to hold a 49 percent stake in the company, while the rest will be held by the foreign promoters. The foreign promoters have spent on a production facility in Hyderabad. NPIL is expected to earn Rs50 crore from its food additives business in 1999-2000. (ag)

Comment:

Signs 3-way tie-up with a British and a US company for manufacturing food additives

Joint ventures, Food Additives, All Other Basic Organic Chemical Manufacturing, Article

---

NPIL GOES HERBAL, GETS INTO JV WITH AYURVEDA FIRM

Article Abstract:

Nicholas Piramal India Ltd (NPIL), a pharmaceutical company, has made 50:50 tie-up with Shree Dhootapapeshwar (SD) of Maharashtra. SD makes ayurvedic medicines. The tie-up is NPIL's first foray into the herbal drugs market. The joint venture company, Solumix Piramal Ltd (SPL), will sell 16 medicines of the ethical products division of SD. This division will be acquired by SPL along with its field staff of 100. The tie-up will offer NPIL inputs for its new focus on phyto-chemistry research at the Hoechst Research Centre. (ag)

Product introduction, Medicinal and Botanical Manufacturing, Organic Medicinals NEC, Bulk drugs, Solumix Piramal Ltd, Shree Dhootapapeshwar

Similar abstracts:

• Abstracts: BORL SET TO ROLL DESPITE DELAYS COSTING OVER RS 2,000 CRORE OIL DEMAND AND PRODUCTION
• Abstracts: ANZ SCRAPS OLD JOBS FOR NEW ONES KVBL TO SET UP HOUSING, INSURANCE SUBSIDIARIES
• Abstracts: BE COOL, ETHNIC OR PLAIN WITH TITAN ECO CITIZEN
• Abstracts: GENISYS PLANS TO HIKE ITS INVESTMENT TO Rs45 CR IN INDIA. CYBER LAW TO GIVE DIGITAL SIGNATURES LEGAL SANCTION

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.